Affected Systems |
|
|
|
|
|
behavior/neurological
|
√
|
|
|
|
abnormal sleep pattern
|
√
|
|
|
|
cardiovascular system
|
|
|
√
|
|
increased heart weight
|
|
|
√
|
|
cellular
|
√
|
|
|
|
impaired macrophage phagocytosis
|
√
|
|
|
|
growth/size/body
|
|
|
√
|
|
increased heart weight
|
|
|
√
|
|
increased body mass index
|
|
|
√
|
|
increased body weight
|
|
|
√
|
|
increased body length
|
|
|
√
|
|
increased susceptibility to diet-induced obesity
|
|
|
√
|
|
enlarged liver
|
|
|
√
|
|
increased liver weight
|
|
|
√
|
|
increased spleen weight
|
|
|
√
|
|
hematopoietic system
|
√
|
√
|
√
|
|
impaired macrophage phagocytosis
|
√
|
|
|
|
decreased T cell number
|
|
√
|
|
|
increased leukocyte cell number
|
|
√
|
|
|
increased B cell number
|
|
√
|
|
|
abnormal spleen morphology
|
|
√
|
|
|
increased spleen weight
|
|
|
√
|
|
abnormal spleen marginal zone morphology
|
|
√
|
|
|
decreased IgA level
|
|
√
|
|
|
decreased IgG1 level
|
√
|
|
|
|
decreased IgG2a level
|
√
|
|
|
|
decreased IgG3 level
|
√
|
|
|
|
increased IgM level
|
√
|
|
|
|
homeostasis/metabolism
|
√
|
|
√
|
√
|
increased susceptibility to diet-induced obesity
|
|
|
√
|
|
decreased circulating interferon-gamma level
|
√
|
|
|
|
increased susceptibility to injury
|
|
|
|
√
|
immune system
|
√
|
√
|
√
|
√
|
impaired macrophage phagocytosis
|
√
|
|
|
|
decreased T cell number
|
|
√
|
|
|
increased leukocyte cell number
|
|
√
|
|
|
increased B cell number
|
|
√
|
|
|
abnormal spleen morphology
|
|
√
|
|
|
increased spleen weight
|
|
|
√
|
|
abnormal spleen marginal zone morphology
|
|
√
|
|
|
decreased circulating interferon-gamma level
|
√
|
|
|
|
absent Peyer's patches
|
|
√
|
|
|
absent lymph nodes
|
|
√
|
|
|
abnormal humoral immune response
|
|
√
|
|
|
decreased IgA level
|
|
√
|
|
|
decreased IgG1 level
|
√
|
|
|
|
decreased IgG2a level
|
√
|
|
|
|
decreased IgG3 level
|
√
|
|
|
|
increased IgM level
|
√
|
|
|
|
decreased interferon-gamma secretion
|
√
|
|
|
|
decreased susceptibility to experimental autoimmune encephalomyelitis
|
|
|
|
√
|
decreased susceptibility to induced arthritis
|
√
|
|
|
|
increased susceptibility to bacterial infection
|
√
|
|
|
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
√
|
|
|
|
decreased susceptibility to parasitic infection
|
|
|
|
√
|
increased susceptibility to parasitic infection
|
|
√
|
|
|
increased susceptibility to Poxviridae infection
|
|
√
|
|
|
increased susceptibility to Riboviria infection
|
|
√
|
|
|
limbs/digits/tail
|
|
|
√
|
|
long tibia
|
|
|
√
|
|
liver/biliary system
|
|
|
√
|
|
enlarged liver
|
|
|
√
|
|
increased liver weight
|
|
|
√
|
|
hepatic steatosis
|
|
|
√
|
|
mortality/aging
|
√
|
√
|
|
√
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
√
|
|
|
|
decreased susceptibility to induced morbidity/mortality
|
|
√
|
|
|
increased susceptibility to induced morbidity/mortality
|
|
√
|
|
√
|
skeleton
|
√
|
|
√
|
|
decreased susceptibility to induced arthritis
|
√
|
|
|
|
long tibia
|
|
|
√
|
|